Abstract
Six of 50 (12%) patients with chronic hepatitis C who were treated with interferon developed thyroid disease or an autoimmune thyroid reaction while undergoing treatment. One patient developed silent thyroiditis, with an increase in serum tri-iodothyronine (T3), thyroxine (T4), free T3, free T4, and markedly suppressed thyroid-stimulating hormone (TSH) levels, accompanied by the appearance of both antithyroglobulin (TgAb) and antimicrosomal antibodies (McAb). One patient developed hypothyroidism in association with moderately elevated TSH levels and high titers of McAb. TSH, TgAb, and McAb levels returned to the initial values at least 4 months after the end of interferon treatment (9 months of follow up). Four patients whose TgAb and/or McAb levels were elevated during treatment with interferon had been diagnosed as having subclinical autoimmune thyroiditis; however, their thyroid function remained in the normal range. These results suggested that treatment with interferon can cause a transient autoimmune thyroid reaction and disease as a side effect.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Choo Q-L, Kuo G, Weiner AJ, et al.. Isolation of cDNA clone derived from a blood bone non-A non-B viral hepatitis genome. Science 1989;244:359–362.
Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A non-B hepatitis. Science 1989;244:362–364.
Okamoto H, Okada S, Sugiyama Y et al. The 5′-terminal sequence of hepatitis C virus genome. Jpn J Exp Med 1990;60:167–177.
Hoofnagle J, Di Bisceglie AM. Treatment of chronic type C hepatitis with alpha interferon. Semin Liver Dis 1989;9:259–263.
Shindo M, Di Bisceglie AM, Cheung L, et al. Decrease in serum hepatitis C viral RNA during alpha interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115:700–704.
Burman PIA, Totterman TH, Oberg K, et al. Thyroid autoimmunity in patients on long-term therapy with leukocytederived interferon. J Clin Endocrinol Metab 1986;63:1086–1090.
Giles FJ, Worman CP, Jewell AP, et al. Recombinant alphainterferons, thyroid irradiation and thyroid disease. Acta Haematol 1991;85:160–163.
Nakamotomo A, Inagaki Y, Kitano Y, et al., A case of chronic active hepatitis type C associated with hyperthyroidism following a long-term interferon therapy (in Japanese). Acta Hepatol Jpn 6:1991;32:863–867.
Maccari S, Bassi C, Giovannini AG, et al. A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy. Clin Rheumatol 1991;10:452–454.
Marcellin P, Pouteau M, Renard P, et al. Sustained hypothyroidism induced by recombinant α interferon in patients with chronic hepatitis C. Gut 1992;33:855–856.
Sauter NP, Atkins MB, Mier JW, Lechan RM. Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-α therapy for metastatic carcinoma. Am J Med 1992;92:441–444.
Taniguchi Y, Murakami T, Nakanishi K, et al. Two cases of hypothyroidism associated with alpha-interferon therapy. Intern Med 1992;31:373–376.
Lisker-Melman M, Di Bisceglie AM, Usala SJ, et al. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 1992;102:2155–2160.
Fentiman IS, Balkwill FR, Thomas BS, et al. An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 1988;24:1299–1303.
Schultz M, Muller R, von zur Muhlen A, et al. Induction of hyperthyroidism by interferon α-2b. Lancet 1989;June 24:1452.
Conlon KC, Urba WJ, Smith JW, et al. Exacerbation of symptoms of autoimmune disease in patients receiving alphainterferon therapy. Cancer 1990;65:2237–2242.
Pichert G, Jost LM, Zobeli L, et al. Thyroiditis after treatment with interleukin-2 and interferon α-2a. Br J Cancer 1990;62:100–104.
Ronnblom LE, Alm GV, Oberg KE. Autoimmunity after alphainterferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115:178–183.
Mayet W-J, Hess G, Gerken G, et al. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989;10:24–28.
Pagliacci MC, Pelicci G, Schippa AM et al. Does interferon-β therapy induce thyroid autoimmune phenomena? Horm Metab Res 1991;23:196–197.
Berris B, Feinman V. Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 1991;36:1657–1660.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kodama, T., Katabami, S., Kamijo, K. et al. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. J Gastroenterol 29, 289–292 (1994). https://doi.org/10.1007/BF02358367
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02358367